首页 | 官方网站   微博 | 高级检索  
     

左氧氟沙星与加替沙星治疗下呼吸道感染的药物经济学分析
引用本文:李燕华,刘林生.左氧氟沙星与加替沙星治疗下呼吸道感染的药物经济学分析[J].中国当代医药,2012(24):153-154.
作者姓名:李燕华  刘林生
作者单位:广东医学院附属三水医院
基金项目:广东省佛山市医学科学技术研究计划项目(2011545)
摘    要:目的评价左氧氟沙星与加替沙星治疗下呼吸道感染的成本-效果分析。方法将70例下呼吸道感染患者随机分为左氧氟沙星组35例和加替沙星组35例,观察两组的疗效、不良反应。结果左氧氟沙星组和加替沙星组总有效率分别为97.14%和97.14%,差异无统计学意义(P>0.05);治疗成本分别1789.92元和2052.16元;左氧氟沙星组成本效果比(C/E)为18.43,加替沙星组成本效果比(C/E)为21.13。结论使用左氧氟沙星治疗下呼吸道感染是一种较好方案。

关 键 词:左氧氟沙星  加替沙星  下呼吸道感染  药物经济学

Pharmacoeconomics analysis on treatment of lower respiratory tract infection with levofloxacin and gatifloxacin
Authors:LI Yanhua  LIU Linsheng
Affiliation:Sanshui Affiliated Hospital of Guangdong Medical College,Foshan 528100,China
Abstract:Objective To evaluate the cost-effectiveness analysis of lower respiratory tract infection treated with leofloxacin and gatifloxacin.Methods Seventy cases were randomly divided into two groups,35 cases were in levofloxacin group and 35 cases were in gatifloxacin group,and the efficacy and adverse reactions were observed.Results The total effective rates of levofloxacin group and gatifloxacin group were 97.14%and 97.14%respectively,there was no statistically significant(P> 0.05);the treatment cost was RMB 1 789.92 yuan and RMB 2 052.16 yuan respectively;C/E of levofloxacin was 18.43 and C/E of gatifloxacin was 21.13.Conclusion Levofloxacin is a better method in treating lower respiratory tract infection.
Keywords:Levofloxacin  Gatifloxacin  Lower respiratory tract infection  Pharmacoeconomics
本文献已被 CNKI 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司    京ICP备09084417号-23

京公网安备 11010802026262号